Global Swine Vaccines Sales 麻豆原创 Report, Competitive Analysis and Regional Opportunities 2025-2031

Publication ID:

PB504253400

Publication Date:

April 3, 2025

Pages:

102

Publisher:

MRRPB5

Countries:

Global [1]

USD 4,250.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The global Swine Vaccines market size was US$ 1491 million in 2024 and is forecast to a readjusted size of US$ 1954 million by 2031 with a CAGR of 4.0% during the forecast period 2025-2031.
The immune system responds by producing antibodies that destroy the infectious agents, usually in co-operation with specialised body cells or by neutralising the toxins that are responsible for the disease. This process of stimulating immunity is called vaccination.

Vaccines contain antigens from viruses, bacteria, bacterial toxins, or parasites. They are given to pigs, usually by injection, to stimulate an immune response which will protect the pigs against later natural infection with the organism from which the vaccine was derived. Most stimulate both a humoral response and a cell-mediated response.

Vaccines can either contain viable organisms that will multiply in the pig, or inactivated ones that will not multiply in the pig.
China is the largest region of Swine Vaccines, with a share more than 40%, followed by Europe and North America, etc. Merck, Boehringer Ingelheim, Jinyu Bio-Technology, CAHIC and Tecon are the top 5 manufacturers of industry, and they had a more than 55% combined market share.
The global Swine Vaccines market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
麻豆原创 Segmentation
By Company:
Merck
Boehringer Ingelheim
Jinyu Bio-Technology
CAHIC
Tecon
Zoetis
Ceva
Hile Bio
Chopper Biology
WINSUN
Hipra
Ringpu Biology
ChengDu Tecbond
DHN
CAVAC
Virbac
HVRI
Bioveta
By Type: (Dominant Segment vs High-Margin Innovation)
CSF Vaccines
FMD Vaccines
Porcine Circovirus Vaccines
PRRS Vaccines
Others
By Application: (Core Demand Driver vs Emerging Opportunity)
Government Tender
麻豆原创 Sales
By Region
Macro-Regional Analysis: 麻豆原创 Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local 麻豆原创 Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Merck in Europe)
- Emerging Product Trends: CSF Vaccines adoption vs. FMD Vaccines premiumization
- Demand-Side Dynamics: Government Tender growth in China vs. 麻豆原创 Sales potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus 麻豆原创s:
North America
Europe
China
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Swine Vaccines market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis 鈥� Uncovering blue ocean markets (e.g., FMD Vaccines in China).
Chapter 5: Application-based segmentation analysis 鈥� High-growth downstream opportunities (e.g., 麻豆原创 Sales in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles 鈥� Financials, product portfolios, and strategic developments.
Chapter 8: 麻豆原创 dynamics 鈥� Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled 麻豆原创 Entry: Navigate regulatory complexities in focus markets (e.g., China鈥檚 policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., CSF Vaccines dominance in Europe vs. FMD Vaccines demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Swine Vaccines Product Scope
1.2 Swine Vaccines by Type
1.2.1 Global Swine Vaccines Sales by Type (2020 & 2024 & 2031)
1.2.2 CSF Vaccines
1.2.3 FMD Vaccines
1.2.4 Porcine Circovirus Vaccines
1.2.5 PRRS Vaccines
1.2.6 Others
1.3 Swine Vaccines by Application
1.3.1 Global Swine Vaccines Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Government Tender
1.3.3 麻豆原创 Sales
1.4 Global Swine Vaccines 麻豆原创 Estimates and Forecasts (2020-2031)
1.4.1 Global Swine Vaccines 麻豆原创 Size in Value Growth Rate (2020-2031)
1.4.2 Global Swine Vaccines 麻豆原创 Size in Volume Growth Rate (2020-2031)
1.4.3 Global Swine Vaccines Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 麻豆原创 Size and Prospective by Region
2.1 Global Swine Vaccines 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
2.2 Global Swine Vaccines Retrospective 麻豆原创 Scenario by Region (2020-2025)
2.2.1 Global Swine Vaccines Sales 麻豆原创 Share by Region (2020-2025)
2.2.2 Global Swine Vaccines Revenue 麻豆原创 Share by Region (2020-2025)
2.3 Global Swine Vaccines 麻豆原创 Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Swine Vaccines Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Swine Vaccines Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging 麻豆原创 Analysis
2.4.1 North America Swine Vaccines 麻豆原创 Size and Prospective (2020-2031)
2.4.2 Europe Swine Vaccines 麻豆原创 Size and Prospective (2020-2031)
2.4.3 China Swine Vaccines 麻豆原创 Size and Prospective (2020-2031)
3 Global 麻豆原创 Size by Type
3.1 Global Swine Vaccines Historic 麻豆原创 Review by Type (2020-2025)
3.1.1 Global Swine Vaccines Sales by Type (2020-2025)
3.1.2 Global Swine Vaccines Revenue by Type (2020-2025)
3.1.3 Global Swine Vaccines Price by Type (2020-2025)
3.2 Global Swine Vaccines 麻豆原创 Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Swine Vaccines Sales Forecast by Type (2026-2031)
3.2.2 Global Swine Vaccines Revenue Forecast by Type (2026-2031)
3.2.3 Global Swine Vaccines Price Forecast by Type (2026-2031)
3.3 Different Types Swine Vaccines Representative Players
4 Global 麻豆原创 Size by Application
4.1 Global Swine Vaccines Historic 麻豆原创 Review by Application (2020-2025)
4.1.1 Global Swine Vaccines Sales by Application (2020-2025)
4.1.2 Global Swine Vaccines Revenue by Application (2020-2025)
4.1.3 Global Swine Vaccines Price by Application (2020-2025)
4.2 Global Swine Vaccines 麻豆原创 Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Swine Vaccines Sales Forecast by Application (2026-2031)
4.2.2 Global Swine Vaccines Revenue Forecast by Application (2026-2031)
4.2.3 Global Swine Vaccines Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Swine Vaccines Application
5 Competition Landscape by Players
5.1 Global Swine Vaccines Sales by Players (2020-2025)
5.2 Global Top Swine Vaccines Players by Revenue (2020-2025)
5.3 Global Swine Vaccines 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Swine Vaccines as of 2024)
5.4 Global Swine Vaccines Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Swine Vaccines, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Swine Vaccines, Product Type & Application
5.7 Global Key Manufacturers of Swine Vaccines, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America 麻豆原创: Players, Segments, Downstream and Major Customers
6.1.1 North America Swine Vaccines Sales by Company
6.1.1.1 North America Swine Vaccines Sales by Company (2020-2025)
6.1.1.2 North America Swine Vaccines Revenue by Company (2020-2025)
6.1.2 North America Swine Vaccines Sales Breakdown by Type (2020-2025)
6.1.3 North America Swine Vaccines Sales Breakdown by Application (2020-2025)
6.1.4 North America Swine Vaccines Major Customer
6.1.5 North America 麻豆原创 Trend and Opportunities
6.2 Europe 麻豆原创: Players, Segments, Downstream and Major Customers
6.2.1 Europe Swine Vaccines Sales by Company
6.2.1.1 Europe Swine Vaccines Sales by Company (2020-2025)
6.2.1.2 Europe Swine Vaccines Revenue by Company (2020-2025)
6.2.2 Europe Swine Vaccines Sales Breakdown by Type (2020-2025)
6.2.3 Europe Swine Vaccines Sales Breakdown by Application (2020-2025)
6.2.4 Europe Swine Vaccines Major Customer
6.2.5 Europe 麻豆原创 Trend and Opportunities
6.3 China 麻豆原创: Players, Segments, Downstream and Major Customers
6.3.1 China Swine Vaccines Sales by Company
6.3.1.1 China Swine Vaccines Sales by Company (2020-2025)
6.3.1.2 China Swine Vaccines Revenue by Company (2020-2025)
6.3.2 China Swine Vaccines Sales Breakdown by Type (2020-2025)
6.3.3 China Swine Vaccines Sales Breakdown by Application (2020-2025)
6.3.4 China Swine Vaccines Major Customer
6.3.5 China 麻豆原创 Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Merck
7.1.1 Merck Company Information
7.1.2 Merck Business Overview
7.1.3 Merck Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Merck Swine Vaccines Products Offered
7.1.5 Merck Recent Development
7.2 Boehringer Ingelheim
7.2.1 Boehringer Ingelheim Company Information
7.2.2 Boehringer Ingelheim Business Overview
7.2.3 Boehringer Ingelheim Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Boehringer Ingelheim Swine Vaccines Products Offered
7.2.5 Boehringer Ingelheim Recent Development
7.3 Jinyu Bio-Technology
7.3.1 Jinyu Bio-Technology Company Information
7.3.2 Jinyu Bio-Technology Business Overview
7.3.3 Jinyu Bio-Technology Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Jinyu Bio-Technology Swine Vaccines Products Offered
7.3.5 Jinyu Bio-Technology Recent Development
7.4 CAHIC
7.4.1 CAHIC Company Information
7.4.2 CAHIC Business Overview
7.4.3 CAHIC Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.4.4 CAHIC Swine Vaccines Products Offered
7.4.5 CAHIC Recent Development
7.5 Tecon
7.5.1 Tecon Company Information
7.5.2 Tecon Business Overview
7.5.3 Tecon Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Tecon Swine Vaccines Products Offered
7.5.5 Tecon Recent Development
7.6 Zoetis
7.6.1 Zoetis Company Information
7.6.2 Zoetis Business Overview
7.6.3 Zoetis Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Zoetis Swine Vaccines Products Offered
7.6.5 Zoetis Recent Development
7.7 Ceva
7.7.1 Ceva Company Information
7.7.2 Ceva Business Overview
7.7.3 Ceva Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Ceva Swine Vaccines Products Offered
7.7.5 Ceva Recent Development
7.8 Hile Bio
7.8.1 Hile Bio Company Information
7.8.2 Hile Bio Business Overview
7.8.3 Hile Bio Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Hile Bio Swine Vaccines Products Offered
7.8.5 Hile Bio Recent Development
7.9 Chopper Biology
7.9.1 Chopper Biology Company Information
7.9.2 Chopper Biology Business Overview
7.9.3 Chopper Biology Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Chopper Biology Swine Vaccines Products Offered
7.9.5 Chopper Biology Recent Development
7.10 WINSUN
7.10.1 WINSUN Company Information
7.10.2 WINSUN Business Overview
7.10.3 WINSUN Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.10.4 WINSUN Swine Vaccines Products Offered
7.10.5 WINSUN Recent Development
7.11 Hipra
7.11.1 Hipra Company Information
7.11.2 Hipra Business Overview
7.11.3 Hipra Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Hipra Swine Vaccines Products Offered
7.11.5 Hipra Recent Development
7.12 Ringpu Biology
7.12.1 Ringpu Biology Company Information
7.12.2 Ringpu Biology Business Overview
7.12.3 Ringpu Biology Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Ringpu Biology Swine Vaccines Products Offered
7.12.5 Ringpu Biology Recent Development
7.13 ChengDu Tecbond
7.13.1 ChengDu Tecbond Company Information
7.13.2 ChengDu Tecbond Business Overview
7.13.3 ChengDu Tecbond Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.13.4 ChengDu Tecbond Swine Vaccines Products Offered
7.13.5 ChengDu Tecbond Recent Development
7.14 DHN
7.14.1 DHN Company Information
7.14.2 DHN Business Overview
7.14.3 DHN Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.14.4 DHN Swine Vaccines Products Offered
7.14.5 DHN Recent Development
7.15 CAVAC
7.15.1 CAVAC Company Information
7.15.2 CAVAC Business Overview
7.15.3 CAVAC Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.15.4 CAVAC Swine Vaccines Products Offered
7.15.5 CAVAC Recent Development
7.16 Virbac
7.16.1 Virbac Company Information
7.16.2 Virbac Business Overview
7.16.3 Virbac Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.16.4 Virbac Swine Vaccines Products Offered
7.16.5 Virbac Recent Development
7.17 HVRI
7.17.1 HVRI Company Information
7.17.2 HVRI Business Overview
7.17.3 HVRI Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.17.4 HVRI Swine Vaccines Products Offered
7.17.5 HVRI Recent Development
7.18 Bioveta
7.18.1 Bioveta Company Information
7.18.2 Bioveta Business Overview
7.18.3 Bioveta Swine Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.18.4 Bioveta Swine Vaccines Products Offered
7.18.5 Bioveta Recent Development
8 Swine Vaccines Manufacturing Cost Analysis
8.1 Swine Vaccines Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Swine Vaccines
8.4 Swine Vaccines Industrial Chain Analysis
9 麻豆原创ing Channel, Distributors and Customers
9.1 麻豆原创ing Channel
9.2 Swine Vaccines Distributors List
9.3 Swine Vaccines Customers
10 Swine Vaccines 麻豆原创 Dynamics
10.1 Swine Vaccines Industry Trends
10.2 Swine Vaccines 麻豆原创 Drivers
10.3 Swine Vaccines 麻豆原创 Challenges
10.4 Swine Vaccines 麻豆原创 Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 麻豆原创 Size Estimation
12.1.1.3 麻豆原创 Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer

Companies Mentioned:

Merck
Boehringer Ingelheim
Jinyu Bio-Technology
CAHIC
Tecon
Zoetis
Ceva
Hile Bio
Chopper Biology
WINSUN
Hipra
Ringpu Biology
ChengDu Tecbond
DHN
CAVAC
Virbac
HVRI
Bioveta

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.